Eczematous reaction to IVIG for the treatment of dermatomyositis
The use of high-dose intravenous immunoglobulin (IVIG) is an accepted therapy for patients with refractory dermatomyositis. Cases of eczematous reactions to IVIG have been reported in the literature, but to our knowledge, none in patients being treated for dermatomyositis. We report on the cases of...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2018-09-01
|
| Series: | International Journal of Women's Dermatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352647518300157 |